×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Thyrocare Technologies Limited | 1828.5 | 360.5 | 1788.9 | 6.78 | 7,005 | 65.8 |
| KOVAI MEDICAL CENTER & HOSPITA | NA | NA | NA | NA | 6900 | 119.0 |
| SUN PHARMA ADVANCED RESEARCH C | 187.8 | -518.7 | 96.4 | -1.6 | 5384 |
Thyrocare Technologies Limited, with Security Code 539871, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 124.8 | 123.6 | 136.3 | 122.9 | 141.2 | 143.6 | 163.1 | 152.5 | 173.9 | 178.9 |
| Expenses | 102.1 | 90.5 | 99.7 | 92.4 | 107.6 | 101.3 | 114.3 | 112.3 | 118.2 | 122.4 |
| Operating Profit | 22.8 | 33.1 | 36.6 | 30.5 | 33.6 | 42.4 | 48.8 | 40.2 | 55.7 | 56.5 |
| OPM % | 18.24% | 26.79% | 26.88% | 24.84% | 23.78% | 29.49% | 29.92% | 26.38% | 32.01% | 31.59% |
| Other Income | 2.1 | 0.5 | 1.8 | 2.1 | 2.8 | 3.2 | 2.1 | 3.5 | 4.5 | 4.0 |
| Interest | 0.6 | 0.8 | 1.0 | 1.0 | 0.9 | 0.9 | 0.6 | 0.5 | 0.6 | 0.6 |
| Depreciation | 9.4 | 8.5 | 9.3 | 10.9 | 10.4 | 9.5 | 9.9 | 15.3 | 11.8 | 9.0 |
| Profit before tax | 14.8 | 24.3 | 28.1 | 20.8 | 25.1 | 35.1 | 40.3 | 27.9 | 47.8 | 50.9 |
| Tax % | -33% | -31.1% | -27.9% | -28.3% | -23.2% | 28.4% | 26.7% | 31.2% | -54% | 29.2% |
| Net Profit | 9.9 | 16.7 | 20.3 | 14.9 | 19.2 | 25.2 | 29.6 | 19.2 | 22.0 | 36.1 |
| EPS in Rs | 1.88 | 3.16 | 3.83 | 2.8 | 3.63 | 4.74 | 5.58 | 3.51 | 0 | 6.78 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 128.0 | 135.9 | 134.9 | 148.0 | 134.7 | 154.3 | 156.9 | 177.4 | 165.9 | 187.2 |
| Expenses | 100.2 | 111.2 | 100.4 | 110.5 | 103.2 | 120.4 | 114.6 | 129.4 | 124.4 | 130.1 |
| Operating Profit | 27.9 | 24.7 | 34.5 | 37.5 | 31.6 | 33.8 | 42.3 | 48.0 | 41.6 | 57.1 |
| OPM % | 21.76% | 18.17% | 25.58% | 25.35% | 23.45% | 21.92% | 26.95% | 27.06% | 25.05% | 30.51% |
| Other Income | 2.6 | 3.7 | 1.0 | 2.2 | 2.7 | 3.3 | 3.6 | 2.6 | 4.0 | 4.6 |
| Interest | 0.6 | 0.7 | 0.9 | 1.1 | 1.1 | 1.1 | 1.0 | 0.8 | 0.6 | 0.7 |
| Depreciation | 10.2 | 10.8 | 9.8 | 10.7 | 13.5 | 13.1 | 11.4 | 13.1 | 17.1 | 13.8 |
| Profit before tax | 19.2 | 16.9 | 24.8 | 27.9 | 19.8 | 23.1 | 33.6 | 36.8 | 27.9 | 47.2 |
| Tax % | -25.5% | -28.1% | -30.9% | -28.4% | -26.1% | -25% | -28.3% | -27.9% | -31.9% | -53.5% |
| Net Profit | 14.7 | 12.5 | 17.3 | 20.3 | 14.7 | 17.2 | 23.9 | 26.4 | 19.0 | 21.6 |
| EPS in Rs | 2.77 | 2.36 | 3.25 | 3.84 | 2.77 | 3.54 | 4.51 | 4.98 | 3.56 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -2% |
| 3 Years: | -14% |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 16% |
| 1 Year: | 60% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | -17% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 16% |
| 1 Year: | 60% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|